Latest News and Press Releases
Want to stay updated on the latest news?
-
PLEASANTON, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced a broad range of new products at the Advances in Genome Biology and Technology (AGBT) General...
-
PLEASANTON, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today reported financial results for the fourth quarter and full year ended December 31, 2019. Recent...
-
PLEASANTON, Calif., Feb. 04, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2019 after...
-
PLEASANTON, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare...
-
PLEASANTON, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it has begun shipping its Visium Spatial Gene Expression Solution. The Visium Spatial Gene Expression...
-
PLEASANTON, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today reported financial results for the third quarter ended September 30, 2019. Recent Highlights ...
-
PLEASANTON, Calif., Oct. 25, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2019 after market close on Thursday, November...
-
PLEASANTON, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the closing of its initial public offering of 11,500,000 shares of its Class A common stock, which...
-
PLEASANTON, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (“10x Genomics”) today announced the pricing of its initial public offering of its Class A common stock at a price of $39.00...